Organogenesis Holdings Inc.

NasdaqCM:ORGO 주식 보고서

시가총액: US$383.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Organogenesis Holdings 대차 대조표 상태

재무 상태 기준 확인 6/6

Organogenesis Holdings 의 총 주주 지분은 $263.5M 이고 총 부채는 $63.5M, 이는 부채 대 자기자본 비율을 24.1% 로 가져옵니다. 총자산과 총부채는 각각 $443.2M 및 $179.7M 입니다. Organogenesis Holdings 의 EBIT는 $13.9M 이며 이자보상배율은 6.7 입니다. $89.9M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

24.1%

부채 비율

US$63.49m

부채

이자 보상 비율6.7x
현금US$89.90m
주식US$263.50m
총 부채US$179.66m
총 자산US$443.16m

최근 재무 상태 업데이트

Recent updates

Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S

Sep 09
Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S

We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Jun 15
We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Organogenesis Holdings: Small-Cap Biotech With Inconsistent Earnings And A Powerful Catalyst

Jun 10

Investors Can Find Comfort In Organogenesis Holdings' (NASDAQ:ORGO) Earnings Quality

May 21
Investors Can Find Comfort In Organogenesis Holdings' (NASDAQ:ORGO) Earnings Quality

Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price

May 01
Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price

Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

Apr 10
Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

May 31
Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?

Jan 19
Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?

Organogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' Portfolio

Oct 18

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Sep 23
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Organogenesis gets FDA clearance for PuraPly MZ for wound healing

Aug 15

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Has Caught The Eye Of Investors

Jul 28
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Has Caught The Eye Of Investors

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Jun 10
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Organogenesis Holdings: What Now

May 18

The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Earnings Yet

Mar 31
The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Earnings Yet

These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

Mar 04
These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

재무 상태 분석

단기부채: ORGO 의 단기 자산 ( $234.2M )이 단기 부채( $85.7M ).

장기 부채: ORGO 의 단기 자산( $234.2M )이 장기 부채( $93.9M ).


부채 대 자본 내역 및 분석

부채 수준: ORGO 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: ORGO 의 부채 대 자기자본 비율은 지난 5년간 315.3% 에서 24.1% 로 감소했습니다.

부채 범위: ORGO 의 부채는 영업 현금 흐름 ( 34.5% )에 의해 잘 충당되었습니다.

이자 보장: ORGO 의 부채에 대한 이자 지급EBIT( 6.7 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기